

Mastercard to use digital technology to deliver health services

MasterCard Aid NetworkMastercard has signed a Memorandum of Understanding (MoU) with Gilead Sciences, Inc. to explore the potential use of the Mastercard Aid Network to simplify the delivery of hepatitis C treatment in a resource limited setting with high disease burden.


The collaboration with Gilead is the first instance where the closed-loop, points-based Mastercard Aid Network would be used in a healthcare context.

An estimated 150 million people worldwide are infected with hepatitis C, with the vast majority of those people living in low- and lower-middle income countries. Many of these countries lack government funded national treatment programs for hepatitis C, the majority of healthcare expenditure being through out-of-pocket payments.


Under the MoU, the parties will discuss the development of a digitized tool, including a monitoring and evaluation feature, that healthcare providers can use in a small-scale pilot to facilitate successful treatment outcomes.

“Our goal is to expand access to effective treatment for chronic hepatitis C”, said Gregg Alton, executive vice president, Corporate and Medical Affairs, Gilead Sciences. “In exploring the potential use of this technology in a resource poor setting, we hope to better provide essential medicines and services to patients.”





Most Popular in 2019

Need tickets?
Search Icon
Btm LogoVisit Site